UnitedHealth Group is scheduled to report second-quarter results on Tuesday morning, capping a tumultuous first half of the year for the health insurance giant.

The disclosure sent UNH shares tumbling 4.7%, reflecting investor unease with the ongoing troubles with the healthcare stock. This admission adds to a string of challenges that have battered the company, with its stock now trading 56% below its 52-week high.

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S. equity market regained its strength in the second quarter,

UnitedHealth's stock drop offers a rare value opportunity given recent acquisitions. UNH maintains industry-leading margins and growth. See more here.

The healthcare conglomerate said it was complying with requests from the agency after reaching out following media reports.

We recently published 12 Stocks Jim Cramer Talked About. UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer recently discussed. UnitedHealth Group Incorporated (NYSE:UNH) is one of the largest healthcare benefits providers in America.

UnitedHealth Group’s diversified revenue and Optum’s innovation provide a resilient foundation for long-term growth. Learn more about UNH stock here.

In this video, I will talk about UnitedHealth Group (UNH-4.82%) and why buying the stock before it reports earnings could make sense. Watch the short video to learn more, consider subscribing, and click the special offer link below.

UnitedHealth Group (UNH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month,